Published in Biochem J on April 15, 1992
Synthesis and characterization of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: neuropathy target esterase. Biochem J (1994) 1.17
Peptide glyoxals: a novel class of inhibitor for serine and cysteine proteinases. Biochem J (1993) 0.87
Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics. Bioorg Med Chem Lett (2013) 0.82
A Selective Irreversible Inhibitor of Furin Does Not Prevent Pseudomonas Aeruginosa Exotoxin A-Induced Airway Epithelial Cytotoxicity. PLoS One (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem (1979) 9.06
Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. J Biol Chem (1962) 7.31
Determination of the operational molarity of solutions of bovine alpha-chymotrypsin, trypsin, thrombin and factor Xa by spectrofluorimetric titration. Biochem J (1973) 2.77
Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry (1982) 2.51
Peptidyl diazomethyl ketones are specific inactivators of thiol proteinases. J Biol Chem (1981) 2.29
Sensitive assays for trypsin, elastase, and chymotrypsin using new fluorogenic substrates. Anal Biochem (1977) 2.12
Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol (1981) 1.82
Application of the nitrocellulose transfer technique and alkaline phosphatase conjugated anti-immunoglobulin for determination of the specificity of monoclonal antibodies to protein mixtures. J Immunol Methods (1982) 1.76
Enzyme immunoassays for the detection of bacterial antigens utilizing biotin-labeled antibody and peroxidase biotin--avidin complex. J Immunol Methods (1983) 1.73
Conversion of proinsulin to insulin: involvement of a 31,500 molecular weight thiol protease. Proc Natl Acad Sci U S A (1982) 1.70
The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor. Biochem J (1989) 1.36
Diazomethyl ketone substrate derivatives as active-site-directed inhibitors of thiol proteases. Papain. Biochemistry (1977) 1.30
The reactivity of His-57 in chymotrypsin to alkylation. Arch Biochem Biophys (1971) 1.13
The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole. Biochem J (1984) 1.07
Zymogen/enzyme discrimination using peptide chloromethyl ketones. J Biol Chem (1989) 1.04
Biotinylation of human C3. Mol Immunol (1982) 1.02
Application of the avidin-biotin-peroxidase complex (ABC) method to the light microscopic localization of pituitary hormones. J Histochem Cytochem (1982) 0.96
A new technique for removal of amorphous phase tissue water without ice crystal damage: a preparative method for ultrastructural analysis and immunoelectron microscopy. J Histochem Cytochem (1986) 0.94
New fluorogenic peptide substrates for plasmin. J Biochem (1980) 0.93
The synthesis, kinetic characterization and application of a novel biotinylated affinity label for cathepsin B. Biochem J (1992) 0.93
Design of fluorescent probes for an enzyme on the surface of tumour cells. J Chromatogr (1986) 0.91
Iodination of peptidyl chloromethyl ketones for protease affinity labels. Anal Biochem (1988) 0.91
The inactivation of the cysteinyl exopeptidases cathepsin H and C by affinity-labelling reagents. Biochem J (1989) 0.89
Substrates for cytochemical demonstration of enzyme activity. II. Some dihalo-3-indolyl phosphates and sulfates. J Med Chem (1966) 0.81
Amino-acids and peptides. Part 48. Synthesis of bradykinyl-chloromethane. Int J Pept Protein Res (1983) 0.80
Tumor cell proteinase visualization and quantification using a fluorescent transition-state analog probe. Proc Natl Acad Sci U S A (1984) 0.78
Isolation and characterization of four proteases from porcine pituitary neurointermediate lobes: relationship to the maturation enzyme of prohormones. Neuropeptides (1985) 0.78
Catastrophic shifts in ecosystems. Nature (2001) 25.57
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68
The autopsy as a measure of accuracy of the death certificate. N Engl J Med (1985) 5.78
Ecology. The value of nature and the nature of value. Science (2000) 5.32
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Purification and properties of Drosophila heat shock activator protein. Science (1987) 4.60
Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol (2001) 4.48
A soluble CD4 protein selectively inhibits HIV replication and syncytium formation. Nature (1988) 4.15
Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation (1992) 3.98
Streptococcal anti-desoxyribonuclease B: microtechnique determination. J Lab Clin Med (1968) 3.88
Use of the objective structured clinical examination for assessment of vocational trainees for general practice. J R Coll Gen Pract (1987) 3.28
Concentrations of free glucogenic amino acids in livers of rats subjected to various metabolic stresses. Biochem J (1967) 3.07
Designed protein pores as components for biosensors. Chem Biol (1997) 2.98
Primary structure of human T-cell receptor alpha-chain. Nature (1985) 2.93
Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences. Science (2010) 2.58
Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med (1999) 2.54
Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Gynecol Oncol (2002) 2.41
Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology (1982) 2.38
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging (2000) 2.26
Single-molecule recognition imaging microscopy. Proc Natl Acad Sci U S A (2004) 2.25
Brain aging and midlife tofu consumption. J Am Coll Nutr (2000) 2.25
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
The influence of human immunodeficiency virus-1 on hematopoiesis. Blood (1998) 2.15
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15
Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry (1997) 2.15
Design of aging intervention studies: the NIA interventions testing program. Age (Dordr) (2008) 2.14
Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: prototypes of pore-forming bacterial cytolysins. Arch Microbiol (1996) 2.11
Development of the human corpus callosum during childhood and adolescence: a longitudinal MRI study. Prog Neuropsychopharmacol Biol Psychiatry (1999) 2.10
MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene (2006) 2.07
An efficient approach to converting three-dimensional image data into highly accurate computational models. Philos Trans A Math Phys Eng Sci (2008) 2.05
The reemergence of smokeless tobacco. N Engl J Med (1986) 2.00
Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens (1998) 1.96
Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 1.84
Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin Exp Immunol (2002) 1.81
Depression and multiple sclerosis. Neurology (1996) 1.79
Cause of ill health and natural death in badgers in Gloucestershire. Vet Rec (1979) 1.75
Mechanisms of protection induced by attenuated simian immunodeficiency virus. II. Lymphocyte depletion does not abrogate protection. AIDS Res Hum Retroviruses (1998) 1.73
Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol (2004) 1.67
Childhood-onset schizophrenia: progressive brain changes during adolescence. Biol Psychiatry (1999) 1.66
Tear gas--harassing agent or toxic chemical weapon? JAMA (1989) 1.66
Mechanisms of protection induced by attenuated simian immunodeficiency virus. I. Protection cannot be transferred with immune serum. J Gen Virol (1997) 1.62
Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A (1997) 1.58
Highly asymmetric transcription by RNA polymerase containing phage-SP01-induced polypeptides and a new host protein. Proc Natl Acad Sci U S A (1975) 1.57
Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1989) 1.55
A transdominant tat mutant that inhibits tat-induced gene expression from the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci U S A (1990) 1.55
Heterogeneity of the alpha subunit of tubulin and the variability of tubulin within a single organism. J Cell Biol (1976) 1.54
Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect Immun (1980) 1.52
Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J Exp Med (1997) 1.52
Identification and expression of a human cytomegalovirus early glycoprotein. J Virol (1989) 1.50
Identification of NG, NG-dimethylarginine in a nuclear protein from the lower eukaryote physarum polycephalum homologous to the major proteins of mammalian 40S ribonucleoprotein particles. Biochem Biophys Res Commun (1977) 1.48
Cloned fragment of the hepatitis delta virus RNA genome: sequence and diagnostic application. Science (1986) 1.46
Delayed density-dependence in a small-rodent population. Proc Biol Sci (1995) 1.46
Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood (1995) 1.45
Accuracy of tympanic temperature readings in children under 6 years of age. Pediatr Nurs (1999) 1.43
An upper limit on the stochastic gravitational-wave background of cosmological origin. Nature (2009) 1.42
Imaging thermally damaged tissue by Polarization Sensitive Optical Coherence Tomography. Opt Express (1998) 1.41
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. J Clin Oncol (1996) 1.41
Creation of a gilded trap by the high economic value of the Maine lobster fishery. Conserv Biol (2011) 1.41
Air quality and public health. J Natl Med Assoc (1997) 1.39
Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus. J Virol (1995) 1.38
Localization and characterization of the hippuricase activity of group B streptococci. Infect Immun (1973) 1.37
Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood (1992) 1.36
Identification of intron and exon sequences involved in alternative splicing of insulin receptor pre-mRNA. J Biol Chem (1998) 1.35
Properties of delta-associated ribonucleic acid. Prog Clin Biol Res (1983) 1.34
Action spectra and adaptation properties of carp photoreceptors. J Gen Physiol (1973) 1.33
Food production, population growth, and the environment. Science (1998) 1.32
Reactive lymphoid hyperplasia with single class (monoclonal) surface immunoglobulin. Am J Clin Pathol (1983) 1.32
Binding properties of octaaminocryptands. Inorg Chem (2000) 1.29
Hemoglobin A1c levels in children and adolescents with diabetes mellitus. Diabetes Care (1981) 1.28
Insensitivity to anti-müllerian hormone due to a mutation in the human anti-müllerian hormone receptor. Nat Genet (1995) 1.27
The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Cancer Res (2001) 1.27
Alopecia areata and cytomegalovirus infection in twins: genes versus environment? J Am Acad Dermatol (1998) 1.27
Visual complexity in letter-by-letter reading: "pure" alexia is not pure. Neuropsychologia (1998) 1.24
Protecting children from lead poisoning and building healthy communities. Am J Public Health (1999) 1.23
Leukaemia near Massachusetts nuclear power plant. Lancet (1987) 1.23
Peri-prosthetic bone mineral density after total knee arthroplasty. Cemented versus cementless fixation. J Bone Joint Surg Br (2006) 1.22
Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir. J Infect Dis (1999) 1.21
The management of persistent menopausal symptoms with oestradiol-testosterone implants: clinical, lipid and hormonal results. Maturitas (1984) 1.21
Molecular architecture of a toxin pore: a 15-residue sequence lines the transmembrane channel of staphylococcal alpha-toxin. EMBO J (1996) 1.21
Massachusetts' approach to the prevention of heart disease, cancer, and stroke. Public Health Rep (1986) 1.20
Phase I and pharmacokinetic trial of weekly CPT-11. J Clin Oncol (1993) 1.20
Memory complaints in nondemented men predict future pathologic diagnosis of Alzheimer disease. Neurology (2004) 1.19
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial. Vaccine (2010) 1.19
The synthesis of peptidylfluoromethanes and their properties as inhibitors of serine proteinases and cysteine proteinases. Biochem J (1986) 1.17
Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin Immunol Immunopathol (1982) 1.14
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm Res (2000) 1.14
Protease-activated receptor-2 involvement in hypotension in normal and endotoxemic rats in vivo. Circulation (1999) 1.13
Perinatal outcome after in-vitro fertilization-surrogacy. Hum Reprod (1999) 1.13
Adenosine A3 receptor stimulation inhibits migration of human eosinophils. J Leukoc Biol (1997) 1.12
Evaluation of waist-mounted tri-axial accelerometer based fall-detection algorithms during scripted and continuous unscripted activities. J Biomech (2010) 1.11
Immunogenicity of a recombinant human immunodeficiency virus (HIV)-canarypox vaccine in HIV-seronegative Ugandan volunteers: results of the HIV Network for Prevention Trials 007 Vaccine Study. J Infect Dis (2003) 1.11
Detection of HIV in enterochromaffin cells in the rectal mucosa of an AIDS patient. Am J Gastroenterol (1989) 1.11
Gene organisation determines evolution of function in the chicken MHC. Immunol Rev (1999) 1.11
Barth syndrome: clinical features and confirmation of gene localisation to distal Xq28. Am J Med Genet (1993) 1.11
Ionic, histological and vascular factors in the reaction of the sheep's parotid to high and low mineralocorticoid status. J Physiol (1969) 1.10
Immunogenicity following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine. Vaccine (2009) 1.10
The relationship between assessed obstetric risk and maternal-perinatal outcome. J Fam Pract (1989) 1.09
Full range polarization-sensitive Fourier domain optical coherence tomography. Opt Express (2004) 1.09